Navigation Links
National Personal Injury Lawyers, TorHoerman Law, Provides Yaz Lawsuit Update
Date:7/31/2012

CHICAGO, July 31, 2012 /PRNewswire/ -- The one-time poster child of birth control prescriptions, Yaz (and Yasmin) has quickly become one of the riskiest oral contraceptives available.

Released in 2006, the contraceptive Yaz generated sales of nearly $2 billion in its first year alone, making it the one time leading birth control pill on the market and Bayer HealthCare Pharmaceutical's top-selling drug.

But in 2012, Bayer is facing over 15,000 lawsuits involving this same blockbuster drug.

Promoted as the choice for women seeking relief from premenstrual symptoms and acne, Yaz's marketing touted the birth control pill as one with multiple benefits. "Yaz is the only birth control pill proven to treat the physical and emotional premenstrual symptoms that are severe enough to impact your life," claimed many of the advertisements; advertising statements that have since been removed.

Instead, recent studies have shown that this marketing was not only misleading but also dangerous. These independent studies have found that Yaz carries higher blood clotting risks than other leading birth control pills.

The attorneys at TorHoerman Law are actively representing women affected by the life-altering side effects of Yaz and Yasmin. The most common injuries involve women who have suffered stroke, Deep Vein Thrombosis (DVT) or Pulmonary Embolism after taking Yaz or Yasmin.

In their second quarter financial statements, Bayer announced that agreements had been reached to settle the claims of 1,877 claimants in the U.S. for a total amount of about $402.6 million. These numbers increased since the first quarter, when Bayer announced they had settled the claims of 651 plaintiffs in the U.S. for a total amount of about $142 million.

TorHoerman Law urges any women that experienced any of these side effects to contact an experienced attorney soon to investigate whether you have a right to compensation for your injuries. http://www.torhoermanlaw.com

 


'/>"/>
SOURCE TorHoerman Law
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com ... ingestion of their medication by matching users with high quality water pipes within an ... with no commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, ...
Breaking Medicine News(10 mins):